CoChat

Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats

Open access

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Sarcopenia is the age-related decrease of muscle mass and function. Diabetes and obesity are known to be risk factors that exacerbate sarcopenia, but the underlying mechanism of diabetes-related sarcopenia is still unknown. Obese type 2 diabetes SDT fatty rats show early onset of severe diabetes and there have been no reports on the characteristics of their skeletal muscle. Therefore, pathophysiological analyses were performed for the skeletal muscle in these rats. Diabetic male SDT fatty rats were sacrificed at 8, 16, 24, 32 and 40 weeks of age. Age-matched Sprague Dawley (SD) rats were used as the normal control. In addition to biological blood parameters, the soleus and the extensor digitorum longus muscles were examined for muscle weight, histopathology, and protein synthesis and degradation. Muscle grip strength was also examined. These results revealed that the muscle weights of the SDT fatty rats were significantly decreased from 16 weeks of age. The mean cross-sectional area of muscle fibers in the SDT fatty rats decreased from 24 weeks of age. Increased intramyocellular lipid accumulation, identified by immunohistochemistry for adipophilin and TEM, was observed in the SDT fatty rats from 8 weeks of age. Plasma insulin-like growth factor (IGF)-1 levels and muscle strength in the SDT fatty rats decreased at 24 weeks of age and thereafter. These pathophysiological findings have been reported both in sarcopenia in aged humans and in patients with diabetes. In conclusion, the SDT fatty rat was considered to be a useful model for analysis of diabetes-related sarcopenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1293/tox.2017-0064

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Body weight and biochemical parameters. Body weight (A), serum glucose (B), triglyceride (C), total cholesterol (D), insulin (E) and plasma IGF-1 (F) levels. *p<0.05 (t-test); **p<0.01 (t-test).
Fig. 1. Body weight and biochemical parameters. Body weight (A), serum glucose (B), triglyceride (C), total cholesterol (D), insulin (E) and plasma IGF-1 (F) levels. *p<0.05 (t-test); **p<0.01 (t-test).CC BY-NC-ND · PubMed Central
Fig. 2. Weights of skeletal muscles. Soleus weight (A) and EDL weight (B). *p<0.05 (t-test); **p<0.01 (t-test).
Fig. 2. Weights of skeletal muscles. Soleus weight (A) and EDL weight (B). *p<0.05 (t-test); **p<0.01 (t-test).CC BY-NC-ND · PubMed Central
Fig. 3. Cross section of soleus muscle with histochemistry for NADH-TR. (A) and (C): SD rats at 8 and 40 weeks of age, respectively. (B) and (D): SDT fatty rats at 8 and 40 weeks of age, respectively. Bar = 50 μm. NADH-TR.
Fig. 3. Cross section of soleus muscle with histochemistry for NADH-TR. (A) and (C): SD rats at 8 and 40 weeks of age, respectively. (B) and (D): SDT fatty rats at 8 and 40 weeks of age, respectively. Bar = 50 μm. NADH-TR.CC BY-NC-ND · PubMed Central
Fig. 4. Morphometric analysis of cross-sectional fiber area in the soleus by histochemistry for NADH-TR. The mean cross-sectional area of the soleus muscle fibers (predominantly type I fibers). *p<0.05 (t-test).
Fig. 4. Morphometric analysis of cross-sectional fiber area in the soleus by histochemistry for NADH-TR. The mean cross-sectional area of the soleus muscle fibers (predominantly type I fibers). *p<0.05 (t-test).CC BY-NC-ND · PubMed Central
Fig. 5. Cross section of EDL muscle with histochemistry for NADH-TR. (A) and (C): SD rats at 8 and 40 weeks of age, respectively. (B) and (D): SDT fatty rats at 8 and 40 weeks of age, respectively. Bar = 50 μm. NADH-TR.
Fig. 5. Cross section of EDL muscle with histochemistry for NADH-TR. (A) and (C): SD rats at 8 and 40 weeks of age, respectively. (B) and (D): SDT fatty rats at 8 and 40 weeks of age, respectively. Bar = 50 μm. NADH-TR.CC BY-NC-ND · PubMed Central
Fig. 6. Morphometric analysis of cross-sectional fiber area in the EDL by histochemistry for NADH-TR. Mean cross-sectional area of the type I fibers (A) and type IIb fibers (B). **p<0.01 (t-test).
Fig. 6. Morphometric analysis of cross-sectional fiber area in the EDL by histochemistry for NADH-TR. Mean cross-sectional area of the type I fibers (A) and type IIb fibers (B). **p<0.01 (t-test).CC BY-NC-ND · PubMed Central
Fig. 7. Micrographs of a cross section of EDL muscle with immunohistochemistry for adipophilin of an SD rat (A) and SDT fatty rat (B) at 40 weeks of age. Increased numbers of adipophilin-positive granules in the muscle fibers were observed in SDT fatty rats (arrowheads). Bar = 20 μm.
Fig. 7. Micrographs of a cross section of EDL muscle with immunohistochemistry for adipophilin of an SD rat (A) and SDT fatty rat (B) at 40 weeks of age. Increased numbers of adipophilin-positive granules in the muscle fibers were observed in SDT fatty rats (arrowheads). Bar = 20 μm.CC BY-NC-ND · PubMed Central
Fig. 8. Longitudinal electron micrographs of the EDL muscle of an SD rat (A) and SDT fatty rat (B) at 40 weeks of age. There were many intramyocellular lipid droplets between myofibrils closely adherent to mitochondria. Inset: high-power magnification of lipid droplets and intermyofibrillar mitochondria with disrupted internal structures. Bar = 2 μm.
Fig. 8. Longitudinal electron micrographs of the EDL muscle of an SD rat (A) and SDT fatty rat (B) at 40 weeks of age. There were many intramyocellular lipid droplets between myofibrils closely adherent to mitochondria. Inset: high-power magnification of lipid droplets and intermyofibrillar mitochondria with disrupted internal structures. Bar = 2 μm.CC BY-NC-ND · PubMed Central
Fig. 9. mRNA expression of Atrogin-1 (A) and Murf-1 (B) in EDL muscle. *p<0.05 (t-test).
Fig. 9. mRNA expression of Atrogin-1 (A) and Murf-1 (B) in EDL muscle. *p<0.05 (t-test).CC BY-NC-ND · PubMed Central
Fig. 10. Muscle strength (forelimb grip test). **p<0.01 (t-test).
Fig. 10. Muscle strength (forelimb grip test). **p<0.01 (t-test).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

Metadata

Authors
Kemmochi, Y., Ohta, T., Motohashi, Y., Kaneshige, A., Katsumi, S., Kakimoto, K., Yasui, Y., Anagawa-Nakamura, A., Toyoda, K., Taniai-Riya, E., Takahashi, A., Shoda, T., & Yamada, T.
Affiliations
  • Japan Tobacco (Japan) (JP)
  • Toxicology Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 23 Naganuki, Hadano, Kanagawa 257-0024, Japan
  • Niigata University (JP)
Corresponding author
Kemmochi, Yusuke
Venue
Journal of Toxicologic Pathology
Published
2018
Volume
31
Issue
2
Pages
113-123
ISSN
  • 0914-9198 (ISSN-L)
  • 1881-915X
OpenAlex
W2794151638
Cited by
23
References
41
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 1 · 2018: 3
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • Journal of Toxicologic Pathology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
sarcopenia, type 2 diabetes, obesity, skeletal muscle, adipophilin, insulin-like growth factor I, muscle strength, muscle fiber cross-sectional area

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.